Skip to main content
. 2012 Aug 20;7(8):e43023. doi: 10.1371/journal.pone.0043023

Figure 4. Compound 16 reduced LPS-induced inflammation.

Figure 4

(A) Effect of compound 16 (concentrations in µM) or Vehicle on PEA levels (A), mRNA expression levels of iNOS (B) and IL-6 (C) in RAW264.7 treated with vehicle (open bars) or LPS (closed bars). vehicle, 0.1% DMSO; LPS, 0.5 µg/mL. **, P<0.01; ***, P<0.001 vs. vehicle; ##, P<0.01; ###, P<0.001 vs. LPS control, n = 5.